ArticleF1000Research2020
MSclassifier: median-supplement model-based classification tool for automated knowledge discovery.
Article in F1000Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- BamClassifier: a machine learning method for assessing iron deficiency.Scientific reports · 2025Article
- MSclassifier: median-supplement model-based classification tool for automated knowledge discovery.F1000Research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
High-throughput technologies have resulted in an exponential growth of publicly available and accessible datasets for biomedical research. Efficient computational models, algorithms and tools are required to exploit the datasets for knowledge discovery to aid medical decisions. Here, we introduce a new tool, MSclassifier, based on median-supplement approaches to machine learning to enable an automated and effective binary classification for optimal decision making. The MSclassifier package estimates medians of features (attributes) to deduce supplementary data, which is subsequently introduced into the training set for balancing and building superior models for classification. To test our approach, it is used to determine HER2 receptor expression status phenotypes in breast cancer and also predict protein subcellular localization (plasma membrane and nucleus). Using independent sample and cross-validation tests, the performance of MSclassifier is evaluated and compared with well established tools that could perform such tasks. In the HER2 receptor expression status phenotype identification tasks, MSclassifier achieved statistically significant higher classification rates than the best performing existing tool (90.30% versus 89.83%, p=8.62e-3). In the subcellular localization prediction tasks, MSclassifier and one other existing tool achieved equally high performances (93.42% versus 93.19%, p=0.06) although they both outperformed tools based on Naive Bayes classifiers. Overall, the application and evaluation of MSclassifier reveal its potential to be applied to varieties of binary classification problems. The MSclassifier package provides an R-portable and user-friendly application to a broad audience, enabling experienced end-users as well as non-programmers to perform an effective classification in biomedical and other fields of study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.